Novel compounds of the formula I in which R, R
1
, R
1
, X are as defined in Patent claim
1
, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumours.
公式I中的化合物,其中R、R1、R1、X如专利权要求1所定义,是
凝血因子Xa的
抑制剂,可用于预防和/或治疗血栓栓塞病和肿瘤的治疗。